Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

221.45
+1.770.81%
Pre-market: 221.450.00000.00%07:17 EDT
Volume:3.99M
Turnover:885.07M
Market Cap:391.39B
PE:93.83
High:224.37
Open:221.09
Low:220.32
Close:219.68
52wk High:244.81
52wk Low:164.39
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.61
T/O Rate:0.23%
Dividend:6.65
Dividend Rate:3.00%
EPS(TTM):2.36
EPS(LYR):2.36
ROE:6225.00%
ROA:9.81%
PB:-119.69
PE(LYR):93.83

Loading ...

AbbVie to Present at TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 24

ConvaTec FY25 adjusted diluted EPS rises 16% to 17.6 cents

Reuters
·
Feb 24

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Feb 24

BRIEF-Abbvie Announces $380 Million Investments In North Chicago

Reuters
·
Feb 24

AbbVie Invests $380 Million to Expand API Manufacturing in North Chicago

Reuters
·
Feb 24

Abbvie - to Hire 300 People in North Chicago

THOMSON REUTERS
·
Feb 24

Abbvie: Two New Facilities to Add Advanced Manufacturing Capabilities to Support Production of Next-Generation Neuroscience and Obesity Medicines

THOMSON REUTERS
·
Feb 24

Abbvie: in Discussions With Multiple U.S. States About Potential Manufacturing Investments,Anticipates Announcing Additional Investments in 2026

THOMSON REUTERS
·
Feb 24

Abbvie - Construction to Begin in Spring 2026, Operational by 2029

THOMSON REUTERS
·
Feb 24

Abbvie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

THOMSON REUTERS
·
Feb 24

IDEAYA Biosciences Names Dr. Theodora Ross Chief Development Officer

Reuters
·
Feb 23

AbbVie FY 2025 net revenues rise 8.6% to USD 61.16B

Reuters
·
Feb 21

AbbVie Expands IPF Pipeline With New Phase 2a Study of ABBV-142

TIPRANKS
·
Feb 21

AbbVie Initiated at Overweight by Barclays

Dow Jones
·
Feb 20

FDA approves AbbVie venclexta, acalabrutinib supplemental new drug application

TIPRANKS
·
Feb 20

FDA approves AbbVie Venclexta and acalabrutinib combo for previously untreated CLL patients

Reuters
·
Feb 20

Daiwa Securities Raises AbbVie Price Target to $244 From $226, Maintains Outperform Rating

MT Newswires Live
·
Feb 20

AbbVie Keeps Quarterly Dividend at $1.73 a Share, Payable May 15 to Shareholders of Record on April 15

MT Newswires Live
·
Feb 19

Press Release: AbbVie Declares Quarterly Dividend

Dow Jones
·
Feb 19

AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 19